The In Vitro Diagnostics Assessment Team acknowledges that there have been inconsistencies in the intended use statements presented in various Instructions for Use (IFUs) of prequalified malaria Ra
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Molnupiravir (WHOAPI-
In collaboration with the WHO Indonesia Country Office the PQT-IVD Team contributed to a workshop hosted by the Directorate of Pharmaceutical and Medical Devices Resilience, Ministry of Health, Ind
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO has been developing PQ technical specifications for IVDs to detect SARS-CoV-2 nucleic acid (closed systems and open platforms) and
The PQT In Vitro Diagnostics Assessment team held a two day consultation meeting with experts in Geneva to review and finalize proposed performance study requirements for WHO prequalification
The PQT-IVD team held a joint assessment session from 5-9 June in Geneva session to pilot a new assessment model whereby assessors meet for a week during which they work in groups to assess product
The PQT Medicines 6th Annual Medicines Quality Workshop for Manufacturers will take place from 25 to 28 September 2023.
The Prequalification Unit (PQT) is happy to announce the introduction of a revised webpage for the List of Prequalified Active Pharmaceutical Ingredients (APIs).
A second Invitation to Manufacturers of therapeutics against Ebola Virus Disease to submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit is being published
The United Nations Development Programme (UNDP) procures diagnostic tests for Global Fund-supported programmes and supports Member States in accessing high-quality in vitro diagnostics (IVDs), incl
The Prequalification-In Vitro Diagnostics (IVD) team were invited by the US President’s Emergency Plan for AIDS Relief (PEPFAR) to present an overview of the current prequalification process for in
The WHO In Vitro Diagnostics (IVD) Assessment team held a meeting and trained assessors from 2 to 5 May in Geneva, Switzerland.
Nirmatrelvir (WHOAPI-458) manufactured by Z
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO Prequalification Unit (PQT) added the below new products to its prequalified list: